Bicillin L-A en es it fr

Bicillin L-A Brand names, Bicillin L-A Analogs

Bicillin L-A Brand Names Mixture

  • No information avaliable

Bicillin L-A Chemical_Formula


Bicillin L-A RX_link

Bicillin L-A fda sheet

Bicillin L-A msds (material safety sheet)

Bicillin_L-A MSDS

Bicillin L-A Synthesis Reference

No information avaliable

Bicillin L-A Molecular Weight

334.391 g/mol

Bicillin L-A Melting Point


Bicillin L-A H2O Solubility

Slightly soluble (210 mg/L)

Bicillin L-A State


Bicillin L-A LogP


Bicillin L-A Dosage Forms

Powder for solution; Suspension; Tablet

Bicillin L-A Indication

For use in the treatment of severe infections caused by penicillin G-susceptible microorganisms when rapid and high penicillin levels are required.

Bicillin L-A Pharmacology

Penicillin G is a penicillin beta-lactam antibiotic used in the treatment of bacterial infections caused by susceptible, usually gram-positive, organisms. The name "penicillin" can either refer to several variants of penicillin available, or to the group of antibiotics derived from the penicillins. Penicillin G has in vitro activity against gram-positive and gram-negative aerobic and anaerobic bacteria. The bactericidal activity of penicillin G results from the inhibition of cell wall synthesis and is mediated through penicillin G binding to penicillin binding proteins (PBPs). Penicillin G is stable against hydrolysis by a variety of beta-lactamases, including penicillinases, and cephalosporinases and extended spectrum beta-lactamases.

Bicillin L-A Absorption

Rapidly absorbed following both intramuscular and subcutaneous injection. Initial blood levels following parenteral administration are high but transient.

Bicillin L-A side effects and Toxicity

Oral LD50 in rat is 8900 mk/kg. Neurological adverse reactions, including convulsions, may occur with the attainment of high CSF levels of beta-lactams.

Bicillin L-A Patient Information

No information avaliable

Bicillin L-A Organisms Affected

Enteric bacteria and other eubacteria